Eugene P Kadar

6PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsGene and molecular therapyMetabolic medicinePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.

|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.

Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton

|Aug 01, 2024
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor.

Eugene P Kadar, Heather Eng, Amit S Kalgutkar

|Feb 20, 2024
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkers.

Eugene P Kadar, Christopher L Holliman, Manoli Vourvahis

|Feb 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans.

Heather Eng, Alyssa L Dantonio, Eugene P Kadar

|Nov 02, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.

Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson

Pageof 1

Frequent Collaborators

4 joint publications

Amit S Kalgutkar

3 joint publications

Ravi Shankar P Singh

3 joint publications

Nandini C Patel

3 joint publications

Li Di